CEO Nancy Stagliano (File photo, Neuron23)
Updated: Neuron23 launches with $113M financing and eyes dead set on Denali and Biogen
A day after announcing two new funds worth $500 million, Westlake Village BioPartners are announcing their latest company. And it’s a well-heeled neuro startup, making …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.